Search

everythinglearnresearchcommunity

for

Search:↓

Higher levels of certain immune cells and proteins are linked to more severe lupus symptoms.

Personalized treatment considering atopic status and cytokine profiles may help in managing pediatric alopecia areata.

Increased regulatory T cell activity may lead to better outcomes in acute diffuse and total alopecia.

An imbalance between certain immune cells is linked to a chronic skin condition and may be influenced by obesity, smoking, and autoimmune issues.

Increased Treg cells and IL-10 may help quick recovery in acute diffuse and total alopecia.

A substance called miR-1246 may help treat severe hair loss by reducing certain immune cell activities.

Alopecia areata involves immune system imbalances that may lead to depression and anxiety.

Blocking IL-17 signaling may reduce skin inflammation and delay aging.

Platelet-rich plasma may help restore immune balance in bald patches, but its effectiveness in treating hair loss is limited.

Psoriasis involves an imbalance between certain immune cells, and targeting these could help restore skin health.

T cells affect skin cell genes in inflammatory diseases, and therapy can normalize these changes.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

STAT3 signaling is important for healthy skin and hair follicles, and its disruption can lead to skin conditions like atopic dermatitis.

HDAC4 and HDAC7 are crucial for Th17 cell development and could be targeted to treat inflammatory diseases.

The hydrogel patch helps heal diabetic wounds by releasing a healing agent in response to harmful molecules and improving skin regeneration.

Psoriasis involves immune and genetic factors, and understanding these can improve treatments.

JAK inhibitors are effective for treating moderate-to-severe alopecia areata.

Women with PCOS have fewer activated T cells in their ovarian follicles, which might affect fertility.

Lower CD200R1 on certain immune cells is linked to more severe rheumatoid arthritis and immune imbalance.

Alopecia areata causes hair loss due to an immune attack on hair follicles, influenced by genetics and environment.

Deucravacitinib improves symptoms and reduces inflammation in Lichen Planopilaris.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Mouse hair follicle stem cells can help prevent Type 1 Diabetes.

Ustekinumab treatment didn't prevent frontal fibrosing alopecia.

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

IL-17-producing γδ T cells help improve bone healing.

IL-4 and IL-13 might play a role in a type of hair loss similar to alopecia areata.

Targeting CD200 could be a new treatment for rheumatoid arthritis.

Regulatory T cells help heal skin wounds by reducing inflammation and promoting tissue repair.